Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

Intravenous Atropine in Reducing Reperfusion Arrhythmias, Conduction Abnormalities and Hypotension in Inferior ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

People with acute inferior wall myocardial infarction will be given an intravenous drug called atropine that increases the heart rate to check if it prevents heart rhythm disturbances during performing coronary intervention

Inclusion Criteria:

• Acute inferior ST elevation myocardial infarction

Exclusion Criteria:

• Execution of rescur percutaneous coronary intervention after thrombolysis
• Mechanical complications or no reflow or spontaneous reperfusion.
• Prior implantation of permanent or temporary pacemakers
• History of bradycardia, hypotension or ventricular tachycardia with a definitive cause (unrelated to the disease under study)
• Prior coronary artery bypass graft surgery
• Atropine contraindications Unwillingness to participate in the